Bergel, C. C. Et Al. 2025. Second-generation BRAF inhibitor Encorafenib resistance is regulated by NCOA4-mediated iron trafficking in the drug-resistant malignant melanoma cells. SCIENTIFIC REPORTS , no.1 .

Bergel, C. C., Eryılmaz, I. E., Çeçener, G., & Egeli, Ü., (2025). Second-generation BRAF inhibitor Encorafenib resistance is regulated by NCOA4-mediated iron trafficking in the drug-resistant malignant melanoma cells. SCIENTIFIC REPORTS , no.1.

Bergel, Ceyda Et Al. "Second-generation BRAF inhibitor Encorafenib resistance is regulated by NCOA4-mediated iron trafficking in the drug-resistant malignant melanoma cells," SCIENTIFIC REPORTS , no.1, 2025

Bergel, Ceyda C. Et Al. "Second-generation BRAF inhibitor Encorafenib resistance is regulated by NCOA4-mediated iron trafficking in the drug-resistant malignant melanoma cells." SCIENTIFIC REPORTS , no.1, 2025

Bergel, C. C. Et Al. (2025) . "Second-generation BRAF inhibitor Encorafenib resistance is regulated by NCOA4-mediated iron trafficking in the drug-resistant malignant melanoma cells." SCIENTIFIC REPORTS , no.1.

@article{article, author={Ceyda Colakoglu Bergel Et Al. }, title={Second-generation BRAF inhibitor Encorafenib resistance is regulated by NCOA4-mediated iron trafficking in the drug-resistant malignant melanoma cells}, journal={SCIENTIFIC REPORTS}, year=2025}